human colon cancer cell line ht29 (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
99
Structured Review
ATCC
human colon cancer cell line ht29
Human Colon Cancer Cell Line Ht29, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 14124 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+colon+cancer+cell+lines+ht29/HT-29/pm41776188-251-1-7
Average 99 stars, based on 14124 article reviews
Human Colon Cancer Cell Line Ht29, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 14124 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+colon+cancer+cell+lines+ht29/HT-29/pm41776188-251-1-7
Average 99 stars, based on 14124 article reviews
human colon cancer cell line ht29 - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
other:Article Title: Bridging pyrimidine hemicurcumin and Cisplatin: Synthesis, coordination chemistry, and in vitro activity assessment of a novel Pt(II) complex. Article Snippet: The Cell Culture:Article Title: Th17 Cells Secrete TWEAK to Trigger Epithelial–Mesenchymal Transition and Promote Colorectal Cancer Liver Metastasis Article Snippet: 1 Th17 cells secrete TWEAK to trigger epithelial-mesenchymal transition and 1 promote colorectal cancer liver metastasis 2 3 Running title: Th17 cells secrete TWEAK to promote CRLM 4 5 Xin Liu1,#, Xin Wang2,#, Qingxia Yang3,#, Li Luo3, Ziqin Liu3, Xiaoxue Ren3, Kai Lei4, 6 Shangru Li3, Zonglin Xie3, Gaomin Zheng3, Yifan Zhang1, Yijie Hao1, Qianying Zhou3, 7 Yingdong Hou1, Fei Fang2, Wu Song4, Ji Cui4, Jinping Ma4, Wenxuan Xie1, Shunli 8 Shen1, Ce Tang2, Sui Peng2,5,6, Jun Yu2,7, Ming Kuang1,2, Xinming Song4,*, Fang 9 Wang2,*, Lixia Xu2,3,* 10 11 Affiliations 12 1Center of Hepato-Pancreato-Biliary Surgery, The First Affiliated Hospital of Sun Yat-13 sen University, Guangzhou, China 14 2Institute of Precision Medicine, The First Affiliated Hospital of Sun Yat-sen University, 15 Guangzhou, China 16 3Department of Oncology, The First Affiliated Hospital of Sun Yat-sen University, 17 Guangzhou, China 18 4Center of Gastrointestinal Surgery, The First Affiliated Hospital of Sun Yat-sen 19 University, Guangzhou, China.. 20 5Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Sun 21 Yat-sen University, Guangzhou, China 22 6Clinical Trial Unit, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 23 China 24 7Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, 25 The Chinese University of Hong Kong, Hong Kong SAR, China 26 27 #These authors contributed equally.. 28 29 30 AN -23-2123/3414591/can-23-2123.pdf?casa_token=vLp3egQ JTJgAAAAA:aw 5Yypykt7G -xeJC H 3SxYBSPqm D TlLIIm cdU gYKgK039ZjbIsm 7C s6lsM nSB5H TJYj55-TO keQ by U niversidad de M alaga (U M A) user on 10 April 2024 2 *Corresponding Authors: 1 Prof. Xinming Song, Center of Gastrointestinal Surgery, The First Affiliated Hospital 2 of Sun Yat-sen University, Guangzhou, 510080 China. |